Reckitt Benckiser, GB00B24CGK77

Reckitt Benckiser stock holds firm after Bernstein repeats Buy

Published on 08/22/2026 at 10:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Reckitt Benckiser stock has a fresh Bernstein Buy call, while the latest quarterly revenue was p6.41 billion and net profit p652 million.

Trading-Floor der Börse mit Händlern in Anzügen vor großen digitalen Kursdiagramm-Bildschirmen
Reckitt Benckiser Group (ISIN GB00B24CGK77) notiert an der London Stock Exchange im FTSE 100 Index, Illustration mit AI erstellt.

Reckitt Benckiser (GB00B24CGK77) has a fresh Buy rating from Bernstein, and the latest quarterly revenue was p6.41 billion with net profit of p652 million for the quarter ending June 30, as reported on August 21, 2026. The shares last traded at 5,112.00p, with a market cap of £32.46 billion and a 4.22% trailing dividend yield.

Bernstein keeps the call

Bernstein rating update reported by TipRanks says analyst Callum Elliott kept a Buy stance and set a £75.00 target on August 21, 2026. The same report also notes that Reckitt's quarterly revenue for the period ending June 30 was p6.41 billion, down from p6.98 billion a year earlier, while net profit fell to p652 million from p958 million.

Latest numbers matter

Stockopedia's market snapshot puts Reckitt at 5,112.00p, or £51.12 per share, with a market capitalization of £32.46 billion and a trailing PE ratio of 14.71. Its consensus recommendation is Buy, the dividend yield is 4.22%, and the share price was 7.62% below the 200-day moving average.

The comparison is more telling than the label: revenue declined by p570 million year over year, while net profit dropped by p306 million. That leaves the 4.22% yield and 14.71 times trailing earnings as the main valuation anchors in the current setup.

Brands still drive cash flow

Reckitt's portfolio still runs through household and health brands such as Lysol, Dettol, Finish, Vanish, Durex, Strepsils, Gaviscon, Mucinex, Nurofen, and Mead Johnson Nutrition. Those brands span consumer health, hygiene, and home care, which helps explain why analysts keep a close eye on margin recovery and volume trends.

Shares and outlook

Reckitt Benckiser stock last changed hands at 5,112.00p on August 21, 2026, with the company valued at £32.46 billion and the 12-month return still muted versus the broader market. The next earnings event is listed as Half Year 2026 Reckitt Benckiser Group PLC Earnings Release, and the market will use that to test whether the June quarter weakness was a temporary dip or a wider trend.

More on Reckitt Benckiser

Investor Relations

Disclaimer...

en | GB00B24CGK77 | RECKITT BENCKISER | boerse | 69985097 | bgmi